Literature DB >> 30890560

The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme.

Prajna Shanbhogue1,2, Reece M Hoffmann3, Michael V Airola1, Rohan Maini1, David J Hamelin3, Miguel Garcia-Diaz4, John E Burke3, Yusuf A Hannun5,2,4,6.   

Abstract

Neutral sphingomyelinase 2 (nSMase2) produces the bioactive lipid ceramide and has important roles in neurodegeneration, cancer, and exosome formation. Although nSMase2 has low basal activity, it is fully activated by phosphatidylserine (PS). Previous work showed that interdomain interactions within nSMase2 are needed for PS activation. Here, we use multiple approaches, including small angle X-ray scattering, hydrogen-deuterium exchange-MS, circular dichroism and thermal shift assays, and membrane yeast two-hybrid assays, to define the mechanism mediating this interdomain interactions within nSMase2. In contrast to what we previously assumed, we demonstrate that PS binding at the N-terminal and juxtamembrane regions of nSMase2 rather acts as a conformational switch leading to interdomain interactions that are critical to enzyme activation. Our work assigns a unique function for a class of linkers of lipid-activated, membrane-associated proteins. It indicates that the linker actively participates in the activation mechanism via intramolecular interactions, unlike the canonical linkers that typically aid protein dimerization or localization.
© 2019 Shanbhogue et al.

Entities:  

Keywords:  ceramide; enzyme mechanism; lipid; sphingolipid; sphingomyelinase

Mesh:

Substances:

Year:  2019        PMID: 30890560      PMCID: PMC6509483          DOI: 10.1074/jbc.RA118.007288

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Prediction of protein secondary structure from circular dichroism using theoretically derived spectra.

Authors:  Caroline Louis-Jeune; Miguel A Andrade-Navarro; Carol Perez-Iratxeta
Journal:  Proteins       Date:  2011-11-17

2.  Conformational changes of Loxosceles venom sphingomyelinases monitored by circular dichroism.

Authors:  Sonia A de Andrade; Matheus F Fernandes Pedrosa; Rute M Gonçalves de Andrade; Maria Luiza Vilela Oliva; Carmen W van den Berg; Denise V Tambourgi
Journal:  Biochem Biophys Res Commun       Date:  2005-02-04       Impact factor: 3.575

3.  Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.

Authors:  Michael V Airola; Prajna Shanbhogue; Achraf A Shamseddine; Kip E Guja; Can E Senkal; Rohan Maini; Nana Bartke; Bill X Wu; Lina M Obeid; Miguel Garcia-Diaz; Yusuf A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

Review 4.  Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Authors:  Achraf A Shamseddine; Michael V Airola; Yusuf A Hannun
Journal:  Adv Biol Regul       Date:  2014-10-27

5.  Cytosolic phospholipase A2α upregulation mediates apoptotic neuronal death induced by aggregated amyloid-β peptide1-42.

Authors:  Chen Sagy-Bross; Nurit Hadad; Rachel Levy
Journal:  Neurochem Int       Date:  2013-09-15       Impact factor: 3.921

Review 6.  Principles of bioactive lipid signalling: lessons from sphingolipids.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

7.  Ceramide triggers budding of exosome vesicles into multivesicular endosomes.

Authors:  Katarina Trajkovic; Chieh Hsu; Salvatore Chiantia; Lawrence Rajendran; Dirk Wenzel; Felix Wieland; Petra Schwille; Britta Brügger; Mikael Simons
Journal:  Science       Date:  2008-02-29       Impact factor: 47.728

8.  Analysis of membrane topology of neutral sphingomyelinase 2.

Authors:  Motohiro Tani; Yusuf A Hannun
Journal:  FEBS Lett       Date:  2007-03-01       Impact factor: 4.124

9.  Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.

Authors:  Natalia Jura; Nicholas F Endres; Kate Engel; Sebastian Deindl; Rahul Das; Meindert H Lamers; David E Wemmer; Xuewu Zhang; John Kuriyan
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

10.  P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest.

Authors:  A A Shamseddine; C J Clarke; B Carroll; M V Airola; S Mohammed; A Rella; L M Obeid; Y A Hannun
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

View more
  6 in total

1.  Remodeling of the interdomain allosteric linker upon membrane binding of CCTα pulls its active site close to the membrane surface.

Authors:  Daniel G Knowles; Jaeyong Lee; Svetla G Taneva; Rosemary B Cornell
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

Review 2.  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.

Authors:  Jan Skácel; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

3.  Role of Neutral Sphingomyelinase-2 (NSM 2) in the Control of T Cell Plasma Membrane Lipid Composition and Cholesterol Homeostasis.

Authors:  Charlene Börtlein; Fabian Schumacher; Burkhard Kleuser; Lars Dölken; Elita Avota
Journal:  Front Cell Dev Biol       Date:  2019-10-15

Review 4.  Vascular Smooth Muscle Cell Neutral Sphingomyelinase 2 in the Release of Exosomes and Vascular Calcification.

Authors:  Angelina Pavlic; Nasim Bahram Sangani; Johanna Kerins; Gerry Nicolaes; Leon Schurgers; Chris Reutelingsperger
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

5.  The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice.

Authors:  Yasunari Matsuzaka; Jun Tanihata; Yoshiko Ooshima; Daisuke Yamada; Masayuki Sekiguchi; Shouta Miyatake; Yoshitsugu Aoki; Mika Terumitsu; Ryu Yashiro; Hirofumi Komaki; Akihiko Ishiyama; Yasushi Oya; Yukiko U Inoue; Takayoshi Inoue; Shin'ichi Takeda; Kazuo Hashido
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

Review 6.  Neutral sphingomyelinase-2 and cardiometabolic diseases.

Authors:  Sardar Sindhu; Yat Hei Leung; Hossein Arefanian; S R Murthy Madiraju; Fahd Al-Mulla; Rasheed Ahmad; Marc Prentki
Journal:  Obes Rev       Date:  2021-03-18       Impact factor: 9.213

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.